Ajanta Pharma shares gain 5% after in-licensing agreement with Biocon for Semgalutide

Biocon will supply semaglutide to Ajanta Pharma for exclusive marketing in 23 countries and semi-exclusive marketing in thee countries across Africa, Centra Asia and the Middle East.

Leave a Reply

Your email address will not be published. Required fields are marked *